These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 790817)

  • 1. [Cytotoxic factor of Flexner shigella, its biologic function and genetic control].
    Bondarenko VM
    Vestn Akad Med Nauk SSSR; 1976; (1):14-21. PubMed ID: 790817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Realization of the cytotoxic properties of Flexner shigellae in a macrophage culture at the cellular and subcellular level].
    Nosova LS; Zhdanov EE; Trofimova MN
    Vestn Akad Med Nauk SSSR; 1976; (1):24-9. PubMed ID: 790819
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of the cytotoxicity of shigellae in the infectious process].
    Dragunskaia EM; Bondarenko VM; Ravdonikas LE; Grabovskaia KB
    Vestn Akad Med Nauk SSSR; 1976; (1):21-4. PubMed ID: 790818
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriological and epidemiological approach to prophylaxis for enteric infection. Effects of peritoneal cells from immunized animals on the infectivity of Shigella bacillus to HeLa cells.
    Sakaguchi T; Sakaguchi S
    Kitasato Arch Exp Med; 1981 Dec; 54(3-4):41-7. PubMed ID: 6759764
    [No Abstract]   [Full Text] [Related]  

  • 5. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
    Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
    Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on phagocytosis of Shigella flexneri by peritoneal macrophages (author's transl)].
    Sakaguchi T; Sakaguchi S; Nakamura I; Okamoto M; Anzai H
    Kansenshogaku Zasshi; 1982 Feb; 56(2):152-61. PubMed ID: 6809853
    [No Abstract]   [Full Text] [Related]  

  • 7. [A possible way of improving colibacterin].
    Shatilo VA; Bondarenko VM
    Mikrobiol Zh (1978); 1984; 46(1):61-6. PubMed ID: 6401093
    [No Abstract]   [Full Text] [Related]  

  • 8. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative susceptibility of animals to Sonne and Flexner dysentery].
    Suptel' IeO; Maksymovych NO; Borysov VA
    Mikrobiol Zh; 1976; 38(6):706-710. PubMed ID: 794642
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacteriological and epidemiological approaches to the prophylaxis of enteric infection. VI. In vitro studies on the mechanism of acquired resistance to Shigella flexneri infection (1).
    Sakaguchi T; Sakaguchi S; Okamoto M; Matsui S; Anzai H
    Kitasato Arch Exp Med; 1980 Dec; 53(3-4):97-109. PubMed ID: 7035741
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity of living attenuated shigellae.
    Serény B; Tenner C; Rácz P
    Acta Microbiol Acad Sci Hung; 1971; 18(4):239-45. PubMed ID: 4950775
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the virulence of an antibiotic-sensitive strain of Flexner dysentery and its exconjugants with different R-factors acquired in the experiment].
    Molochaeva IS
    Vestn Akad Med Nauk SSSR; 1976; (1):69-72. PubMed ID: 790825
    [No Abstract]   [Full Text] [Related]  

  • 15. Salicin-fermenting variant of Shigella flexneri serotype 2a.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1965; 12(1):7-13. PubMed ID: 4952941
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells.
    Klimpel GR; Niesel DW; Klimpel KD
    J Immunol; 1986 Feb; 136(3):1081-6. PubMed ID: 3510252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
    Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro model for the analysis of the interaction between Shigella flexneri and the intestinal epithelium].
    Raygoza-Anaya M; González-Robles A; Mora-Galindo J
    Arch Invest Med (Mex); 1990; 21(4):305-9. PubMed ID: 1669218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 20. [The serologic structure and enzyme properties of Flexner shigellae isolated in Ashkhabad].
    Mel'kumiants NB; Kucherova AM; Markar'ian ES
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):138-9. PubMed ID: 4281243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.